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The effect of Ins 1,3,4,5-P 4 on the intracellular Ca 2 + mobilization produced by Ins 1,4,5-P ahas been exam- 
ined in permeabilized hepatocytes. Ins 1,3,4,5-P 4 did not affect he magnitude of the Ins 1,4,5-P3-mediated 
Ca 2 + release but did inhibit re-accumulation f the released Ca 2 ÷ back into intracellular stores. This effect 
was not mimicked by Ins 1,3,4-P 3. In hepatocytes, the re-uptake phase of the response results from Ins 1,4,5- 
P3 hydrolysis. Measurements u ing labeled substrates indicate that Ins 1,3,4,5-P 4 inhibits the hydrolysis of 
Ins 1,4,5-P 3 and vice versa. Since the removal of the 5-phosphate on Ins 1,4,5-P 3 and Ins 1,3,4,5-P 4 is a 
common step in the disposal of both compounds, it is suggested that one of the biological effects of Ins 
1,3,4,5-P 4 may be to slow hydrolysis of Ins 1,4,5-P aand thereby prolong the duration of a Ca 2 + transient. 
Inositoi tetrakisphosphate; Inositol trisphosphate; Phosphatase; Ca 2 +; (Liver cell) 
1. INTRODUCTION 
Inositol trisphosphate (Ins 1,4,5-P3) is the 
messenger molecule that mediates the intracellular 
Ca 2÷ mobilization that occurs in response to a wide 
variety of cell surface stimuli [1,2]. The metabolic 
pathways involved in its disposal have recently 
been clarified with the discovery that, in addition 
to being dephosphorylated to Ins 1,4-P2, it is also 
phosphorylated by a specific 3-kinase to form 
inositol tetrakisphosphate (Ins 1,3,4,5-P4) [3-5]. 
This compound can then be further 
dephosphorylated to form Ins 1,3,4-P3 [3-5]. 
Although Ins 1,3,4,5-P4 and Ins 1,3,4-P~ ac- 
cumulate in many stimulated cells, they are inac- 
tive in mobilizing intracellular Ca 2+ at low 
concentrations [6,7] and their biological functions 
are presently unknown. It has been proposed that 
Ins 1,3,4,5-P4 may function to regulate Ca 2÷ entry 
across the plasma membrane [5,8]. Here, we have 
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examined the effects of Ins 1,3,4,5-P4 on the in- 
tracellular Ca 2+ mobilization produced by Ins 
1,4,5-P3. We find that the re-uptake phase of the 
trisphosphatase-mediated ca 2+ transient is in- 
hibited by the tetrakisphosphate when added to 
saponin-permeabilized h patocytes. Measurements 
indicate that Ins 1,3,4,5-P4 inhibits the hydrolysis 
of Ins 1,4,5-P~ under these conditions. These data 
suggest hat Ins 1,3,4,5-P4 accumulation i an in- 
tact stimulated cell may slow the hydrolysis of Ins 
1,4,5-P3 and modulate the duration of a cytosolic 
free Ca 2+ transient. 
2. MATERIALS AND METHODS 
The procedures used for isolation and incuba- 
tion of saponin-permeabilized hepatocytes and the 
measurement of free Ca 2÷ concentration changes 
with Ca 2÷ electrodes were as described in [9]. The 
incubation buffer contained (mM): KCI (120), 
NaHepes (20), pH 7.2, MgCI2 (0.3), MgATP (1), 
creatine phosphate (10), together with creatine 
kinase (10 mU/ml), saponin (300/zg/ml) and 1/~M 
each of ruthenium red and antimycin A. Liver cells 
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were added to this buffer at a final concentration 
of 6 mg dry wt/ml. Metabolites of 3H-labeled Ins 
1,4,5-P3 (New England Nuclear) were measured by 
an HPLC method [5]. Ins 1,3,4,5-P4 labeled with 
32p in the 3-position was prepared using 
[7-32p]ATP, Ins 1,4,5-P3 and Ins 1,4,5-P3 3-kinase 
from rat brain as in [10]. Metabolites formed from 
32p-labeled Ins 1,3,4,5-P4 were measured in 
neutralized perchloric acid extracts using small col- 
umns of Dowex AG- IX8 (formate form) anion- 
exchange resins. The elution buffers all contained 
0.1 M formic acid and inositol bis-, tris- and 
tetrakisphosphates were selectively eluted with 
0.4 M (6 ml), 0.8 M (6 ml) and 1.5 M (3 ml) am- 
monium formate, respectively. 
Unlabeled Ins 1,4,5-P3 (free of contaminating 
Ins 2,4,5-P3) was from Behring Diagnostics (La 
Jolla, CA). Ins 1,3,4,5-P4 and Ins 1,3,4-P3 were 
prepared as described [7,10] and the purity of these 
compounds was ascertained by NMR spectroscopy 
[10]. 
3. RESULTS 
Fig. lA shows the time course of Ca z+ release 
produced by a maximal concentration of Ins 
1,4,5-P3 added to saponin-permeabilized 
hepatocytes. As observed in many systems 
[9,11,12] the rapid release of Ca z+ is followed by 
a slower phase of Ca 2+ re-uptake. In agreement 
with previous reports [6,7], Ins 1,3,4,5-P4 alone at 
concentrations up to 10/tM did not alter Ca 2÷ 
fluxes (not shown), nor did it significantly affect 
the amplitude or initial rate of the Ca 2÷ transient 
produced by Ins 1,4,5-P3. However, the presence 
of Ins 1,3,4,5-P4 slowed the re-uptake phase of the 
Ins 1,4,5-P3 response and consequently increased 
the duration of the Ca 2÷ transient. This effect was 
most marked when Ins 1,3,4,5-P4 was present in 
20-fold excess over Ins 1,4,5-P3, but effects could 
still be observed at equimolar concentrations of 
both compounds. In another series of experiments, 
the effect of combining suboptimal concentrations 
of Ins 1,4,5-P3 with Ins 1,3,4,5-P4 was tested 
(fig.2). The lower concentration of Ins 1,4,5-P3 
(0.15/tM) produced a more transient response 
than a maximal concentration (fig.2A and [9]). 
When an equal concentration of Ins 1,3,4,5-P4 was 
included, the duration of the Ca 2÷ transient was 
again increased. In this case Ins 1,3,4,5-P4 
predominantly affected the later stages of the re- 
uptake phase. Higher concentrations of Ins 
1,3,4,5-P4 inhibited over the entire period of re- 
uptake and produced a larger increase in the dura- 
tion of the transient. In three separate ex- 
periments, addition of 0.15#M Ins 1,3,4,5-P4 
produced a 56.1 _ 8.7°70 increase in the time taken 
for the Ca 2+ transient generated by an equal con- 
centration of Ins 1,4,5-P3 to return to baseline. 
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Fig.1. Effect of Ins 1,3,4,5-P4 and Ins 1,3,4-P3 on intracellular Ca 2÷ release induced by a maximal concentration of
Ins 1,4,5-P3. Liver cells (6 mg dry wt/ml) were incubated in a Ca 2+ electrode chamber with saponin in the presence 
of MgATP and an ATP-regenerating system (see section 2). Ca 2÷ accumulation was followed until the system 
approached a steady state (approx. 10 min). At this point, Ins 1,4,5-P3 (0.5/zM) was added and Ca 2÷ release was 
measured. When present, Ins 1,3,4,5-P4 (A) or Ins 1,3,4-P3 (B) was added simultaneously with Ins 1,4,5-P3. 
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Fig.2. Effect of Ins 1,3,4,5-P4 on intracellular Ca 2+ 
release induced by a submaximal dose of Ins 1,4,5-Pa. 
The experimental conditions used were as described in 
fig.1 except hat a lower concentration of Ins 1,4,5-P3 
(0.15 #M) was tested. The traces were obtained using a 
different cell preparation from that in fig.l and 
illustrates that the shape of the Ca 2÷ transient varies 
somewhat between different batches of cells. 
fect on the Ins 1,4,5-P3-mediated Ca z+ transient 
(fig.lB). This suggests that Ins 1,3,4,5-P4 itself, 
rather than its dephosphorylation product, is 
responsible for the observed effects on the Ca 2÷ 
transient. Experimental evidence is available to 
support the view that the re-uptake phase of the 
Ca 2+ response observed in the permeabilized cell 
results from the hydrolysis of Ins 1,4,5-P3, by a 
phosphatase that catalyses the removal of 
phosphate at the 5-position [1,9]. Competition be- 
tween Ins 1,4,5-P3 and Ins 1,3,4,5-P4 for this en- 
zyme [13] would account for the experimental 
data. To test this possibility, the hydrolysis of 
0.5/zM 3H-labeled Ins 1,4,5-P3 was measured in 
the presence and absence of Ins 1,3,4,5-P4. Fig.3A 
shows that when present at equal concentrations 
Ins 1,3,4,5-P4 substantially decreased the initial 
rate of hydrolysis of Ins 1,4,5-P3, while a 20-fold 
excess of Ins 1,3,4,5-P4 had little further effect. 
The major [3H]inositol phosphate product 
detected by HPLC was Ins 1,4-P2. Approx. 10°70 
of the label appeared as Ins 1,3,4-P3 and Ins 3,4-P2 
isomers in the 5 min incubation period (not shown) 
indicating a small but significant flux through Ins 
1,4,5-P3 3-kinase in the permeabilized cell. Fig.3B 
shows that the initial rate of hydrolysis of 0.5 #M 
[32p]Ins 1,3,4,5-P4 was almost 6-fold faster than 
Fig.3. Hydrolysis of labeled inositol polyphosphates by 
saponin-permeabilized hepatocytes. Liver cells were 
treated at a final concentration f 6 mg dry wt/ml with 
240 #g saponin for 10 min at 30°C in a final volume of 
0.8 ml using incubation conditions identical to those 
used for the Ca 2÷ electrode studies. At this time 0.5 #M 
of either [3H]Ins 1,4,5-P3 (0.1 Ci/mmol) or [3-32p]Ins 
1,3,4,5-P4 (10000 cpm/pmol) was added. The 
appropriate unlabeled inositol phosphates were added at 
the same time as the labeled compounds. Samples 
(0.15 ml) were withdrawn at the indicated times and 
quenched in 0.4 ml of 50/0 (w/v) perchloric acid 
containing 1.25 mM Tris EDTA and 0.375 mM 
diethylenetriaminepentaacetic acid. After removal of 
precipitated proteins, the extract was neutralized and 
analyzed by HPLC or Dowex anion-exchange 
chromatography as described in section 2. (A) 
Hydrolysis of 0.5 #M [3H]Ins 1,4,5-P3 was measured in 
the absence (~----o) or presence of 0.5 #M (~---Q) or 
10 #M (A A) Ins 1,3,4,5-P4. (B) Hydrolysis of [32p]Ins 
1,3,4,5-P4 was measured in the absence (~----o) or 
presence of 0.5#M (© ©) or 10#M (~. A) Ins 
1,4,5-P3. 
an equal concentration of [3H]Ins 1,4,5-P3. Ins 
1,3,4,5-P4 hydrolysis was markedly inhibited upon 
addition of 0.5 or 10#M unlabeled Ins 1,4,5-P3. 
4. DISCUSSION 
Removal of the phosphate at the 5-position of 
the inositol ring is a common step in the 
metabolism of both Ins 1,4,5-P3 and Ins 1,3,4,5-P4 
and may be catalyzed by the same enzyme [13,14]. 
Therefore, while Ins 1,3,4,5-P4 is itself inactive in 
mobilizing intracellular Ca 2+, it may indirectly af- 
fect this process by decreasing the rate of Ins 
1,4,5-P3 hydrolysis by the 5'-phosphomonoester- 
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ase. Such an effect has been observed in this study 
using permeabilized hepatocytes. The extent to 
which such interactions occur in the intact 
stimulated cell is unknown, but would presumably 
depend on factors such as the relative amounts of 
Ins 1,4,5-P3 and Ins 1,3,4,5-P4 formed, as well as 
the kinetic parameters of the enzyme(s) involved in 
metabolizing these compounds. 
In any one experimental system the relative 
amounts of 3H-labeled Ins 1,4,5-P3 and Ins 
1,3,4,5-P4 formed appear to vary according to the 
stimuli. For the rat hepatocyte, vasopressin, at 
maximal concentrations, produces approx. 3-times 
more Ins 1,4,5-P3 than Ins 1,3,4,5-P4 over a 30 s 
interval [5]. Under similar conditions o~-adrenergic 
stimulation resulted in approximately equal in- 
creases of both inositol phosphates, while in the 
case of glucagon, the increase of Ins 1,3,4,5-P4 
greatly exceeded that of Ins 1,4,5-P3 [15]. The data 
in figs 1 and 2 suggest hat significant decreases in 
the rate of Ca 2+ re-uptake can be observed when 
Ins 1,4,5-P3 and Ins 1,3,4,5-P4 are present at equal 
concentrations. The relative potency of Ins 
1,3,4,5-P4 in inhibiting the hydrolysis of Ins 
1,4,5-P3 by the 5'-phosphomonoesterase is further 
emphasized from studies on the kinetic properties 
of the purified soluble enzyme from human 
platelets [13] and rat brain [14]. In both cases it 
was found that the apparent Km and Vma× for Ins 
1,3,4,5-P4 hydrolysis (Kin = 0.5-1 .0#M) was 
lower than for Ins 1,4,5-P3 (Km = 3-10/~M). In 
liver [16-18] this enzyme is primarily membrane 
bound and, although a systematic kinetic analysis 
was not undertaken i  this study, it is clear that Ins 
1,3,4,5-Pa is hydrolyzed more rapidly than Ins 
1,4,5-P3 (fig.3). Thus, available information on 
the relative amounts of Ins 1,3,4,5-P4 and Ins 
1,4,5-P3 formed in stimulated cells, as well as the 
kinetic properties of purified 5' -phosphomono- 
esterase, raises the possibility that one of the 
biological effects of Ins 1,3,4,5-P4 formed in a 
stimulated cell may be to prolong the Ca 2+ signal 
mediated by Ins 1,4,5-P3. 
Potentially, competition between substrates for 
the 5'-phosphomonoesterase may also play a role 
in prolonging the effects of Ins 1,3,4,5-P4 on cell 
function. It has recently been shown that microin- 
jection of Ins 2,4,5-Ps together with Ins 1,3,4,5-P4 
activates ea urchin eggs whereas microinjection of 
these compounds separately does not [8]. The 
necessity for co-injection of Ins 2,4,5-P3 was at- 
tributed to its ability to mobilize intracellular Ca 2+ 
without an attendant phosphorylation catalysed by 
3-kinase. It was further proposed that a full activa- 
tion of the egg requires intracellular Ca 2+ 
mobilization as well as an accelerated entry of 
Ca 2+ across the plasma membrane and that the lat- 
ter process could be activated by Ins 1,3,4,5-P4 [8]. 
An additional possibility arising from the present 
data which needs to be considered is that Ins 
2,4,5-P3 may, like Ins 1,4,5-P3 (fig.3B), inhibit the 
rapid hydrolysis of Ins 1,3,4,5-P4 and thereby 
facilitate the expression of the biological effects of 
this molecule on the sea urchin egg. 
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